TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05794217: A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Sponsor: Sanguine Biosciences · Phase: PHASE2 · Area: RARE_ORPHAN · Target Enrollment: 20000 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$16,480,000

Rescue Site Savings

+$10,866,500

Unlock Full NCT05794217 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05794217 Rescue Dossier →